Y10S 435/80
Elimination or reduction of contamination by undersired ferments
Official title: Elimination or reduction of contamination by undersired ferments, e.g. aseptic cultivation
Y10S435/80 (Elimination or reduction of contamination by undersired ferments) appears on 113 US grants and 24 published applications in this corpus.
Search patents in Y10S- Granted patents
- 113
- Published applications
- 24
- Assignees
- 86
- Inventors
- 213
- Latest grant
- 7 Aug 2018
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 6 | 0 |
| 1978 | 4 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 6 | 0 |
| 1982 | 3 | 0 |
| 1983 | 2 | 0 |
| 1984 | 2 | 0 |
| 1985 | 1 | 0 |
| 1986 | 4 | 0 |
| 1987 | 3 | 0 |
| 1988 | 3 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 8 | 0 |
| 1993 | 7 | 0 |
| 1994 | 2 | 0 |
| 1995 | 2 | 0 |
| 1996 | 6 | 0 |
| 1997 | 5 | 0 |
| 1998 | 4 | 0 |
| 1999 | 3 | 0 |
| 2000 | 4 | 0 |
| 2001 | 3 | 0 |
| 2002 | 5 | 2 |
| 2003 | 0 | 5 |
| 2004 | 3 | 1 |
| 2005 | 2 | 2 |
| 2006 | 1 | 0 |
| 2007 | 1 | 5 |
| 2008 | 1 | 1 |
| 2009 | 0 | 1 |
| 2010 | 3 | 0 |
| 2011 | 0 | 0 |
| 2012 | 2 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 0 |
| 2015 | 2 | 2 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 2 | 1 |
| 2019 | 0 | 1 |
By publication year. Applications have been published since 2001.
Recent patents
- Methods of using chimeric receptors to identify autoimmune disease7 Aug 2018US 10,041,943 B2Diagnostic Hybrids, Inc.
- High concentration antibody and protein formulations31 Jul 2018US 10,034,940 B2Genentech, Inc.
- Methods of using chimeric receptors to identify autoimmune disease22 Aug 2017US 9,739,775 B2Diagnostic Hybrids, Inc.
- High concentration antibody and protein formulations24 Feb 2015US 8,961,964 B2Genentech, Inc.
- Methods of using chimeric receptors to identify autoimmune disease6 Jan 2015US 8,926,981 B2Diagnostic Hybrids, Inc.
- High concentration antibody and protein formulations28 Nov 2019US 2019/0358323 A1Genentech, Inc.
- Methods Of Using Chimeric Receptors To Identify Autoimmune Disease22 Feb 2018US 2018/0052159 A1Diagnostic Hybrids, Inc.
- High concentration antibody and protein formulations23 Feb 2017US 2017/0049888 A1Genentech, Inc.
- Methods Of Using Chimeric Receptors To Identify Autoimmune Disease22 Oct 2015US 2015/0301042 A1Diagnostic Hybrids, Inc.
- High concentration antibody and protein formulations13 Aug 2015US 2015/0225485 A1Genentech, Inc.
Most cited
By later US patents
- Reduced-viscosity concentrated protein formulations250US 6,875,432 B2Genentech, Inc. · 2005
- Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to-donor energy transfer system232US 5,849,489 ANanogen, Inc. · 1998
- Hybridization of polynucleotides conjugated with chromophores and fluorophores to generate donor-to donor energy transfer system227US 5,565,322 ANanogen, Inc. · 1996
- Self-organizing molecular photonic structures based on chromophore- and fluorophore-containing polynucleotides and methods of their use127US 5,532,129 AEnterprise Partners II, L.P. · 1996
- Method of reducing viscosity of high concentration protein formulations88US 7,666,413 B2Genetech, Inc. · 2010